Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Photorefractive Keratectomy (PRK) Versus Laser Assisted in Situ Keratomileusis (LASIK) for Hyperopia Correction." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432324/2/Long_term_hormone_therapy_for_perimenopausal_and_postmenopausal_women:_Cochrane_systematic_review. Accessed 18 April 2024.
Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432324/2/Long_term_hormone_therapy_for_perimenopausal_and_postmenopausal_women:_Cochrane_systematic_review. Accessed April 18, 2024.
Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432324/2/Long_term_hormone_therapy_for_perimenopausal_and_postmenopausal_women:_Cochrane_systematic_review
Photorefractive Keratectomy (PRK) Versus Laser Assisted in Situ Keratomileusis (LASIK) for Hyperopia Correction [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432324/2/Long_term_hormone_therapy_for_perimenopausal_and_postmenopausal_women:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction
ID - 432324
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432324/2/Long_term_hormone_therapy_for_perimenopausal_and_postmenopausal_women:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -